Changes of CA19-9 levels and related influencing factors in patients with type 2 diabetes mellitus after antidiabetic therapy
Abstract Abnormalities of carbohydrate antigen 19 − 9 (CA19-9) are common in patients with type 2 diabetes mellitus (T2DM), and in some patients, CA19-9 returns to normal level after glycemic control. The aim of this study was to investigate the factors associated with CA19-9 levels in patients with...
Saved in:
| Main Authors: | Xiafei Zhao, Yan Wang, Ling Zhou, Aili Ye, Quanfeng Zhu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85807-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antidiabetic agents as potential cytotoxic candidates for cancer therapy
by: Alnaser Raniah I., et al.
Published: (2025-06-01) -
Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery
by: Shounak Sarkhel, et al.
Published: (2024-12-01) -
Tratamiento farmacológico de la diabetes mellitus tipo 2
by: Francisco Javier García Soidán, et al.
Published: (2025-04-01) -
Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications
by: Roxana-Cristina Dobriceanu, et al.
Published: (2025-04-01) -
Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study
by: Taku Yamada, et al.
Published: (2023-11-01)